Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H [electronic resource]
Producer: 20201113ISSN:- 1422-0067
- Animals
- Benzodiazepinones -- administration & dosage
- Female
- Gastric Mucosa -- pathology
- Gene Expression Profiling -- methods
- Gene Expression Regulation -- drug effects
- H(+)-K(+)-Exchanging ATPase -- genetics
- Humans
- Hyperplasia -- prevention & control
- In Situ Hybridization
- Injections, Subcutaneous
- Intercellular Signaling Peptides and Proteins -- genetics
- Male
- Metaplasia
- Mice
- Mice, Knockout
- Neuroendocrine Cells -- pathology
- Phenylurea Compounds -- administration & dosage
- Exome Sequencing
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.